News and Views

U.S. Food and Drug Administration (FDA)

Biosimilars and Oral Agents Lead New Approvals in the Cancer Setting

A majority of the U.S. Food and Drug Administration (FDA) approvals for cancer agents in the latter part of 2018 represented second and third approvals for new indications in other disease sites. Many were given expedited approval, but with that comes the potential that the incidence of adverse events may be underrepresented because fewer patients received the agents in a clinical trial setting.

December 18, 2018

Trending Topics

View All Topics

Fitness Trackers Provide Helpful Postsurgical Data on Patients With Cancer

Fitness Trackers Provide Helpful Postsurgical Data on Patients With Cancer

December 17, 2018

FDA Approves Romiplostim for Pediatric Patients With Immune Thrombocytopenia

U.S. Food and Drug Administration (FDA)

FDA Approves Romiplostim for Pediatric Patients With Immune Thrombocytopenia

December 14, 2018

Your Voice Shaped Oncology Nursing and Cancer Care in 2018

Your Voice Shaped Oncology Nursing and Cancer Care in 2018

December 14, 2018

HPV 9-Valent Vaccine Approved for People Aged 27–45

Cancer Prevention

HPV 9-Valent Vaccine Approved for People Aged 27–45

December 12, 2018

Manage Afatinib’s Adverse Events to Keep Patients on Treatment

Manage Afatinib’s Adverse Events to Keep Patients on Treatment

December 11, 2018

ONS Past President Sandra Lee Schafer, RN, MN, AOCN®

ONS Past President Sandra Schafer Leaves a Legacy of Compassionate Leadership

December 10, 2018

Board Looks at Ways to Involve More Members in Chapters

Board Looks at Ways to Involve More Members in Chapters

December 07, 2018

Former President Bush’s Legacy Holds Strong Commitment to Advancing Cancer Care

Former President Bush’s Legacy Holds Strong Commitment to Advancing Cancer Care

December 06, 2018

U.S. Spending on Antineoplastics Nearly Doubles From 2011–2016

U.S. Spending on Antineoplastics Nearly Doubles From 2011–2016

December 05, 2018

How Can Oncology Nurses Support Surgical Patients With Esophageal Cancer?

How Can Oncology Nurses Support Surgical Patients With Esophageal Cancer?

December 04, 2018

Surgical Oncology Nursing

Under the Knife: Supporting Patients’ Needs Throughout Surgical Oncology Care

December 04, 2018

FDA Approves Rituximab-ABBS as Biosimilar to Rituximab for Non-Hodgkin’s Lymphoma

U.S. Food and Drug Administration (FDA)

FDA Approves Rituximab-ABBS as Biosimilar to Rituximab for Non-Hodgkin Lymphoma

November 28, 2018

Researchers Win Nobel Prize for Work in Cancer Immunotherapy

Cancer Research

Researchers Win Nobel Prize for Work in Cancer Immunotherapy

November 28, 2018

$FDA Approves Gilteritinib for Relapsed, Refractory AML With a FLT3 Mutation$

U.S. Food and Drug Administration (FDA)

FDA Approves Gilteritinib for Relapsed, Refractory AML With an FLT3 Mutation

November 28, 2018

FDA Approves Larotrectinib for Solid Tumors With NTRK Gene Fusions

U.S. Food and Drug Administration (FDA)

FDA Approves Larotrectinib for Solid Tumors With NTRK Gene Fusions

November 27, 2018

Comprehensive

APRN-Led Clinics Enable Comprehensive Survivorship Care

November 27, 2018

Chemotherapy Is Still a Staple in Treatment Plans. Here’s a Fresh Look at a Familiar Treatment Option

Chemotherapy Is Still a Staple in Treatment Plans. Here’s a Fresh Look at a Familiar Treatment Option

November 26, 2018

FDA Approves Glasdegib for AML

U.S. Food and Drug Administration (FDA)

FDA Approves Glasdegib for AML in Adults Aged 75 or Older or Who Have Comorbidities

November 26, 2018

FDA Approves Brentuximab Vedotin for Previously Untreated sALCL and CD30-Expressing PTCL

U.S. Food and Drug Administration (FDA)

FDA Approves Brentuximab Vedotin for Previously Untreated sALCL and CD30-Expressing PTCL

November 20, 2018

WHO Cautions About Inactivity Pandemic and Disease Risk

WHO Cautions About Inactivity Pandemic and Disease Risk

November 20, 2018

The Case of the Emotional Emergency

Psychosocial Issues

The Case of the Emotional Emergency

November 20, 2018

The Integrative Oncology Nurse: New Role for a New Era in Cancer Care

Integrative Medicine

The Integrative Oncology Nurse: New Role for a New Era in Cancer Care

November 15, 2018

Research Shows That Telephone Triage Is a Vital Part of Patient Experience

Research Shows That Telephone Triage Is a Vital Part of Patient Experience

November 15, 2018

Recent NSAID Use May Improve Ovarian Cancer Survival

Recent NSAID Use May Improve Ovarian Cancer Survival

November 14, 2018

FDA Grants Accelerated Approval to Pembrolizumab for Hepatocellular Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Pembrolizumab for Hepatocellular Carcinoma

November 13, 2018

An Oncology Nursing Overview of Biosimilars

Clinical Practice

An Oncology Nursing Overview of Biosimilars

November 13, 2018

Supporting the Chapter Model Transition Remains Key Focus for ONS Board

Supporting the Chapter Model Transition Remains Key Focus for ONS Board

November 07, 2018

Tailored Psychotherapy Combats Depression in Advanced Cancer

Psychosocial Issues

Tailored Psychotherapy Combats Depression in Advanced Cancer

November 07, 2018

ONS Tackles Oral Chemotherapy Complexities

ONS Tackles Oral Chemotherapy Complexities

November 06, 2018

How Oncology Nurses Provide Quality Care Through Telephone Triage

Oncology Nurse-Patient Relationship

How Oncology Nurses Provide Quality Care Through Telephone Triage

November 06, 2018

FDA Approves Lorlatinib for Second, Third-Line Treatment of ALK-Positive Metastatic NSCLC

U.S. Food and Drug Administration (FDA)

FDA Approves Lorlatinib for Second, Third-Line Treatment of ALK-Positive Metastatic NSCLC

November 05, 2018

New Edition of Palliative Care Guidelines Focus on Inclusivity, Responsibility

Palliative Care

New Edition of Palliative Care Guidelines Focus on Inclusivity, Responsibility

November 01, 2018

Which RN is Competent in Chemotherapy Administration?

Which RN Is Competent in Chemotherapy Administration?

November 01, 2018

FDA Approves Pembrolizumab in Combination With Chemotherapy for First-Line Treatment of Metastatic Squamous NSCLC

U.S. Food and Drug Administration (FDA)

FDA Approves Pembrolizumab in Combination With Chemotherapy for First-Line Treatment of Metastatic Squamous NSCLC

October 31, 2018

Chapters and Practice-Specific Topics Were on Board Agenda for August

ONS Board of Directors

Chapters and Practice-Specific Topics Were on Board Agenda for August

October 30, 2018

When ONS Speaks, People Listen

When ONS Speaks, People Listen

October 29, 2018

Oral Adherence With Nerlynx® (Neratinib) Tablets: Conversation With an Expert, Part 2

Oral Adherence With Nerlynx® (Neratinib) Tablets: Conversation With an Expert, Part 2

October 26, 2018

Oral Adherence With Nerlynx® (Neratinib) Tablets: Conversation With an Expert, Part 1

Oral Adherence With Nerlynx® (Neratinib) Tablets: Conversation With an Expert, Part 1

October 26, 2018

Oral Adherence With Nerlynx® (Neratinib) Tablets: Patient Case

Oral Adherence With Nerlynx® (Neratinib) Tablets: Patient Case

October 26, 2018

Oral Adherence With Nerlynx® (Neratinib) Tablets: Introduction

Oral Adherence With Nerlynx® (Neratinib) Tablets: Introduction

October 26, 2018

ONS and Other Groups Ask Nurses to Lead by Example to Promote Advance Care Planning

Palliative Care

ONS and Other Groups Ask Nurses to Lead by Example to Promote Advance Care Planning

October 25, 2018

Liquid Biopsy May Predict Breast Cancer Late Recurrence

Liquid Biopsy May Predict Breast Cancer Late Recurrence

October 24, 2018

How Oncology Nurses Support Non-Oncology Units Administering Chemotherapy

How Oncology Nurses Support Non-Oncology Units Administering Chemotherapy

October 23, 2018

Monitoring Surface Contamination of Hazardous Drugs and Considerations for Remediation

Monitoring Surface Contamination of Hazardous Drugs and Considerations for Remediation

October 18, 2018

Neuroendocrine Prostate Cancer Subtype Is Aggressive and More Common Than Expected

Neuroendocrine Prostate Cancer Subtype Is Aggressive and More Common Than Expected

October 17, 2018

FDA Approves Talazoparib for gBRCAm HER2-Negative Locally Advanced or Metastatic Breast Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Talazoparib for gBRCAm HER2-Negative Locally Advanced or Metastatic Breast Cancer

October 16, 2018

What APRNs Need to Know About Right to Try

Advanced Practice Nursing (APRN)

What APRNs Need to Know About Right to Try

October 16, 2018

The Overlooked Link Between Alcohol and Breast Cancer

The Overlooked Link Between Alcohol and Breast Cancer

October 15, 2018

U.S. Pediatric Cancer Incidence Varies by Geography

U.S. Pediatric Cancer Incidence Varies by Geography

October 10, 2018

Back to Top ▲